Sign in
4

Changes in Ownership

Niagen Bioscience, Inc. Filed Acc 0001628280-21-012676

Options or other derivatives

  • Director acquired 20,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Baxter Jeff · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-06-17 Grant or award : show line 1 in the form Stock Options (right to buy) +20,000 20,000 D
Loading xslF345X03/wf-form4_162439725270272.xml…